Massachusetts Wholesale Drug Distributor License Guide

Massachusetts Wholesale Drug Distributor Licensing Guide

Overview

Wholesale drug distributors operating in or shipping into Massachusetts must obtain a license from the Massachusetts Board of Registration in Pharmacy. This requirement applies to both resident distributors with facilities in Massachusetts and non-resident distributors shipping prescription drugs into the state for further distribution. Massachusetts enforces stringent facility, personnel, and record-keeping standards aligned with federal DSCSA requirements and NABP best practices.

Regulatory Authority

The Massachusetts Board of Registration in Pharmacy (MBORP or MA Board of Pharmacy) regulates wholesale drug distribution in the state. The Board operates under statutory authority established in M.G.L. c. 112, §§ 24-42E (Massachusetts Pharmacy Practice Act), which governs pharmaceutical distribution and the Board's regulatory powers. Specific wholesale drug distributor licensing requirements are codified in M.G.L. c. 112, § 36, with implementing regulations at 247 CMR 19.00 (wholesale drug distributor regulations) and 247 CMR 21.00 (pedigree requirements and supply chain integrity). Controlled substance distribution is additionally governed by M.G.L. c. 94C (Massachusetts Controlled Substances Act).

Contact: Massachusetts Board of Registration in Pharmacy, 200 Harvard Mill Square, Suite 210, Wakefield, MA 01880 | Website: https://www.mass.gov/orgs/board-of-registration-in-pharmacy

Who Must Be Licensed

Massachusetts requires wholesale drug distributor licenses for the following entities:

• Resident wholesalers: Any entity located in Massachusetts engaged in wholesale distribution of prescription drugs or devices.
• Non-resident wholesalers: Any out-of-state distributor shipping prescription drugs into Massachusetts for further distribution (not direct to patients).
• Third-party logistics providers (3PLs): 3PLs that take physical possession of prescription drugs must hold a wholesale drug distributor license or specific 3PL license if such a category exists under current regulations.
• Repackagers: Entities that repackage prescription drugs for wholesale distribution require both manufacturing and wholesale distributor licenses.
• Virtual distributors: Entities facilitating wholesale transactions without physical possession may require licensing depending on business model—verification recommended.

Exemptions (verify current exemptions with the Board):

• Manufacturers distributing their own FDA-approved products
• Licensed pharmacies making occasional sales to other licensed pharmacies or practitioners
• Licensed practitioners dispensing to their own patients
• Common carriers acting solely as transporters
• Certain transactions between co-licensed entities within a single corporate family (conditions apply)
• Federal facilities and certain governmental entities

Application Requirements

New wholesale drug distributor license applications require the following documentation:

• Business entity information: Legal business name, all DBAs, FEIN, articles of incorporation/organization, certificate of good standing from state of incorporation, physical address of all facilities, mailing address
• Ownership disclosure: Names, addresses, and dates of birth for all officers, directors, partners, and owners of 5% or more of the business; background disclosure for all listed individuals
• Designated representative: Name, qualifications, resume/CV demonstrating required experience in pharmaceutical distribution (typically 2-3 years—verify exact duration with Board)
• Background checks: CORI (Criminal Offender Record Information) for designated representative and key personnel; disclosure of disciplinary actions, license denials/suspensions/revocations in any state; disclosure of felony or drug-related misdemeanor convictions
• Surety bond: Amount as specified by Board (typically $25,000-$100,000 depending on business type and volume); bond must name Commonwealth of Massachusetts as obligee and be issued by a company authorized to do business in Massachusetts
• Facility documentation: Facility diagram showing layout, storage areas, and security features; description of security systems; description of environmental controls (temperature/humidity monitoring); standard operating procedures for receipt/storage, security, damaged/recalled products, record-keeping, temperature monitoring, and controlled substances
• Other licenses: Copy of DEA registration(s) if handling controlled substances; copy of home state license (non-resident applicants); NABP VAWD accreditation documentation or application status; documentation of DSCSA compliance capabilities
• Record-keeping systems: Description of systems for maintaining drug pedigrees and transaction histories; attestation of capability to comply with Massachusetts and federal pedigree requirements
• Personnel qualifications: Evidence of adequate training and education; training program documentation
• Application fee: Non-refundable fee (verify current amount with Board)

Applicants should be prepared for a pre-licensing facility inspection by Board investigators following initial application review.

Application Process

1. Pre-application consultation: Contact the Board to discuss specific requirements for your business model before formal submission.
2. Prepare documentation: Gather all required materials listed above.
3. Complete application form: Obtain current wholesale drug distributor application from Board website or by contacting Board directly. Verify whether online submission is available or if paper applications with original signatures/notarizations are required.
4. Submit application: Submit completed application with supporting documentation and fee to Massachusetts Board of Registration in Pharmacy, 200 Harvard Mill Square, Suite 210, Wakefield, MA 01880 (verify current mailing address).
5. Application review: Board staff conduct completeness review. Incomplete applications may be returned or held pending missing information.
6. Background checks: Board processes background checks on designated representative and key personnel.
7. Pre-licensing inspection: Board inspectors schedule and conduct on-site facility inspection to verify compliance with physical plant, security, and operational requirements.
8. Board consideration: Complete applications with satisfactory inspection results are presented to the Board at regular monthly meetings.
9. License issuance: Upon Board approval, license is issued. Certificate must be prominently displayed at the licensed facility.
10. DEA registration: If not already obtained, apply for DEA registration for the facility (required for controlled substances).

Processing time: Anticipate 60-120 days from submission of a complete application to license issuance. Times vary based on application completeness, inspection scheduling, and Board meeting schedules. Verify current processing timeframes with the Board.

Out-of-State Requirements

Non-resident wholesale drug distributors shipping prescription drugs into Massachusetts must comply with the following:

• Non-resident license required: Out-of-state distributors must obtain a Massachusetts non-resident wholesale drug distributor license before shipping into the state.
• Home state licensure: Must hold valid, unrestricted wholesale drug distributor license in home state with standards substantially equivalent to Massachusetts requirements.
• Application documentation: Submit same documentation as resident applicants, including completed non-resident application, copy of home state license, DEA registration proof, surety bond, background information on owners/officers/designated representative, facility information and procedures, and application fee.
• Inspection requirements: Board may conduct reciprocal inspections through direct inspection by Massachusetts investigators, review of home state inspection reports, acceptance of NABP VAWD accreditation inspection reports, or coordination with home state inspectors. Current Board practice should be verified.
• Service of process: Must designate Massachusetts Secretary of State or another Massachusetts resident as agent for service of process.
• Compliance obligations: Must comply with all Massachusetts wholesale distribution statutes and regulations, including record-keeping, pedigree requirements, suspicious order reporting, recall response, and notification of license changes or disciplinary actions in other states.
• VAWD accreditation: While not an absolute statutory requirement, NABP VAWD accreditation significantly facilitates interstate licensing and is increasingly expected by trading partners.

Fees

Notes: Application fees are non-refundable. Fees are subject to periodic adjustment through regulatory action. Contact the Board at (617) 727-9953 or check the Board's website for the current fee schedule.

Renewal Requirements

Renewal cycle: Massachusetts wholesale drug distributor licenses are renewed biennially (every two years). Verify the specific renewal date assignment methodology with the Board—renewal dates may be based on initial issuance date or standardized to a specific calendar date.

Renewal process:

• Notification: Board sends renewal notices 60-90 days before expiration via mail or email. Licensees are responsible for timely renewal even if notice is not received.
• Renewal application requirements:

- Confirmation or update of business information

- Confirmation or update of ownership, officers, and designated representative information

- Disclosure of changes in operations, disciplinary actions, or criminal convictions since last renewal

- Attestation of continued compliance with all licensure requirements

- Updated surety bond if previous bond has expired

- Payment of renewal fee

• Submission method: Verify whether renewals are submitted online through the Board's licensing portal or by mail.
• Continuing education: Verify whether Massachusetts requires continuing education for designated representatives or other personnel as a renewal condition.
• Renewal inspection: Board may conduct routine inspections in connection with renewal, though not all renewals trigger inspections.

Grace period: Verify whether Massachusetts provides a grace period for renewal. Some states allow 30 days post-expiration during which the license remains valid; others do not. This must be confirmed with the Board.

Penalties for late renewal or expired license:

• Late renewal fee: If submitted after expiration (or after any grace period), a late penalty fee is assessed in addition to standard renewal fee (verify amount).
• Operating with expired license: Constitutes a violation of Massachusetts pharmacy law and may result in administrative penalties/fines, license discipline, criminal penalties for unlicensed practice, inability to legally distribute prescription drugs, and liability issues.
• Reinstatement: Licenses expired beyond any grace period may require reinstatement rather than late renewal, involving reinstatement application, higher reinstatement fee, updated inspection, demonstration of continuous compliance during expiration period, or potentially a new initial application if expiration has been prolonged.

ColdChainCheck Data Snapshot

Massachusetts presents a mixed compliance landscape among the 23 wholesale drug distributors tracked in ColdChainCheck's directory. The state's 58% active license rate (15 of 26 total licenses) falls below the national benchmark, indicating a notable proportion of expired or inactive licensure on record—a data signal that warrants verification during due diligence. With an average compliance score of 58/100 and median of 55/100, Massachusetts-licensed entities cluster in the "Fair" compliance tier. The presence of 5 NABP-accredited entities (22% of tracked distributors) suggests a subset of the market maintains heightened compliance postures, while universal FDA registration (23/23 entities) reflects baseline federal compliance across the population. Full scoring methodology is available at /methodology.

Top Entities in Massachusetts

The following entities hold the highest compliance scores in Massachusetts based on verified licensure, accreditation status, and regulatory record data:

1. ASD Healthcare — 85/100
2. Cencora — 85/100
3. FISHER BIOSERVICES INC. — 85/100
4. McKesson Corporation — 75/100
5. Cardinal Health — 70/100

Scores in the 70-85 range typically reflect active licensure across multiple jurisdictions, NABP accreditation (where applicable), FDA registration, and absence of recent enforcement actions or recalls. High scores indicate broader data verification coverage rather than qualitative endorsement.

Related Entities

The full Massachusetts wholesale drug distributor directory is available at /directory?state=MA. The directory includes all 23 tracked entities with detailed compliance score breakdowns, license status, accreditation records, and data source citations. ColdChainCheck updates this directory periodically as new license data is ingested from the Massachusetts Board of Registration in Pharmacy and cross-referenced federal sources.

Disclaimer

This guide is provided for informational purposes only and does not constitute legal, regulatory, or compliance advice. Licensing requirements, fees, and procedures are subject to change by the Massachusetts Board of Registration in Pharmacy. Entities should verify all information directly with the Board at (617) 727-9953 or https://www.mass.gov/orgs/board-of-registration-in-pharmacy before submitting applications or making business decisions based on this content.